title: New therapeutic pathways in the RAS.
authors.affiliation: Max-Delbrück-Center for Molecular Medicine, Berlin-Buch, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Bader
authors.forename: Robson A
authors.initials: RA
authors.lastname: Santos
authors.forename: Thomas
authors.initials: T
authors.lastname: Unger
authors.forename: U Muscha
authors.initials: UM
authors.lastname: Steckelings
mesh_terms: D000803:Angiotensin I / Q000494:pharmacology / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D006801:Humans; D010446:Peptide Fragments / Q000494:pharmacology / Q000627:therapeutic use; D044139:Receptor, Angiotensin, Type 2 / Q000819:agonists / Q000378:metabolism; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000187:drug effects
chemical_list: D057911:Angiotensin Receptor Antagonists; D010446:Peptide Fragments; D044139:Receptor, Angiotensin, Type 2; D011994:Recombinant Proteins; D000803:Angiotensin I; C118790:angiotensin I (1-7)